Form 8-K - Current report:
SEC Accession No. 0001213900-25-020942
Filing Date
2025-03-06
Accepted
2025-03-06 09:01:00
Documents
15
Period of Report
2025-02-28
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0233232-8k_pmgchold.htm   iXBRL 8-K 29671
2 CERTIFICATE OF AMENDMENT TO BE FILED ON FEBRUARY 28, 2025 ea023323201ex3-1_pmgchold.htm EX-3.1 7336
3 PRESS RELEASE DATED AS OF MARCH 5, 2025 ea023323201ex99-1_pmgchold.htm EX-99.1 18177
  Complete submission text file 0001213900-25-020942.txt   241495

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE elab-20250228.xsd EX-101.SCH 3027
5 XBRL LABEL FILE elab-20250228_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE elab-20250228_pre.xml EX-101.PRE 22367
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0233232-8k_pmgchold_htm.xml XML 3918
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 25713758
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)